MoS₂-DNA tetrahedral bioconjugate for high-performance DNA biosensors: application in viral infection diagnostics

An electrochemical DNA biosensor is presented for early viral infection detection, integrating molybdenum disulphide (MoS₂), tetrahedral DNA nanostructures (TDNs), and thionine-modified carbon nanodots (CNDsTy). The innovation of this work lies in the first-time integration of these nanomaterials fo...

Descripción completa

Detalles Bibliográficos
Autores: Enebral-Romero, Estefanía, Martínez-Periñán, Emiliano, López-Diego, David, Luna, Mónica, Garrido, Marina, Navío, Cristina, Pérez, Emilio M., Lorenzo, Encarnación, García-Mendiola, Tania
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/390018
Acceso en línea:http://hdl.handle.net/10261/390018
https://api.elsevier.com/content/abstract/scopus_id/105000028126
Access Level:acceso abierto
Palabra clave:Bioconjugate
Biosensor
Differential pulse voltammetry
Molybdenum disulphide
Tetrahedral DNA nanostructures
Thionine-modified carbon nanodots
Descripción
Sumario:An electrochemical DNA biosensor is presented for early viral infection detection, integrating molybdenum disulphide (MoS₂), tetrahedral DNA nanostructures (TDNs), and thionine-modified carbon nanodots (CNDsTy). The innovation of this work lies in the first-time integration of these nanomaterials for the preparation of a bioconjugate, whose synergy enables the biosensor's functionality. MoS₂ anchors the TDNs, which carry the capture probe for virus identification via genetic code recognition. CNDsTy allow the electrochemical detection based on their different affinity for single-stranded (ssDNA) and double-stranded DNA (dsDNA), enabling hybridization event identification. The biosensor achieves high sensitivity (detection limit of 5.00 fM) and can distinguish viral loads, validated with the SARS-CoV-2 ORF1ab sequence in human nasopharyngeal samples.